Pirfenidone limits the progression of malignancy and slows the development of fibrosis in experimental hepatocarcinoma. Scarlet Arceo-Orozco; Fernando Caloca-Camarena; Roberto Flores-Peña; Marina Galicia-Moreno; Hugo Christian Monroy-Ramírez; Juan Armendáriz-Borunda;

Pirfenidone induces translocation of sirt1 to nucleus and deacetylation of histone 3 slows down the development of fibrosis and tumorigenicity in a experimental model of hepatocarcinoma. Hugo C. Monroy-Ramírez; Scarlet Arceo-Orozco; Araceli G. Rivera-Cabral; Marina Galicia-Moreno; Juan Armendáriz-Borunda;

Pirfenidone slows the development of fibrosis and malignant neoplasms by modulating inflammation in an experimental model of hepatocarcinoma. Scarlet Arceo-Orozco; Fernado Caloca-Camarena; Marina Galicia-Moreno; Hugo C. Monroy-Ramírez; Juan Armendáriz-Borunda;